Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1994;89:975-990

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haskell, W. L.
Right arrow Articles by Krauss, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haskell, W. L.
Right arrow Articles by Krauss, R. M.

Circulation, Vol 89, 975-990, Copyright © 1994 by American Heart Association


ARTICLES

Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP)

WL Haskell, EL Alderman, JM Fair, DJ Maron, SF Mackey, HR Superko, PT Williams, IM Johnstone, MA Champagne and RM Krauss
Division of Cardiovascular Medicine, Stanford University, Palo Alto, CA 94304-1583.

BACKGROUND: Recent clinical trials have shown that modification of plasma lipoprotein concentrations can favorably alter progression of coronary atherosclerosis, but no data exist on the effects of a comprehensive program of risk reduction involving both changes in lifestyle and medications. This study tested the hypothesis that intensive multiple risk factor reduction over 4 years would significantly reduce the rate of progression of atherosclerosis in the coronary arteries of men and women compared with subjects randomly assigned to the usual care of their physician. METHODS AND RESULTS: Three hundred men (n = 259) and women (n = 41) (mean age, 56 +/- 7.4 years) with angiographically defined coronary atherosclerosis were randomly assigned to usual care (n = 155) or multifactor risk reduction (n = 145). Patients assigned to risk reduction were provided individualized programs involving a low-fat and -cholesterol diet, exercise, weight loss, smoking cessation, and medications to favorably alter lipoprotein profiles. Computer-assisted quantitative coronary arteriography was performed at baseline and after 4 years. The main angiographic outcome was the rate of change in the minimal diameter of diseased segments. All subjects underwent medical and risk factor evaluations at baseline and yearly for 4 years, and reasons for all hospitalizations and deaths were documented. Of the 300 subjects randomized, 274 (91.3%) completed a follow-up arteriogram, and 246 (82%) had comparative measurements of segments with visible disease at baseline and follow-up. Intensive risk reduction resulted in highly significant improvements in various risk factors, including low-density lipoprotein cholesterol and apolipoprotein B (both, 22%), high-density lipoprotein cholesterol (+12%), plasma triglycerides (-20%), body weight (-4%), exercise capacity (+20%), and intake of dietary fat (- 24%) and cholesterol (-40%) compared with relatively small changes in the usual-care group. No change was observed in lipoprotein(a) in either group. The risk-reduction group showed a rate of narrowing of diseased coronary artery segments that was 47% less than that for subjects in the usual-care group (change in minimal diameter, -0.024 +/- 0.066 mm/y versus -0.045 +/- 0.073 mm/y; P < .02, two-tailed). Three deaths occurred in each group. There were 25 hospitalizations in the risk-reduction group initiated by clinical cardiac events compared with 44 in the usual-care group (rate ratio, 0.61; P = .05; 95% confidence interval, 0.4 to 0.9). CONCLUSIONS: Intensive multifactor risk reduction conducted over 4 years favorably altered the rate of luminal narrowing in coronary arteries of men and women with coronary artery disease and decreased hospitalizations for clinical cardiac events.


This article has been cited by other articles:


Home page
Arch Intern MedHome page
J. Ma, K. Berra, W. L. Haskell, L. Klieman, S. Hyde, M. W. Smith, L. Xiao, and R. S. Stafford
Case Management to Reduce Risk of Cardiovascular Disease in a County Health Care System
Arch Intern Med, November 23, 2009; 169(21): 1988 - 1995.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
L. Aucott, H. Rothnie, L. McIntyre, M. Thapa, C. Waweru, and D. Gray
Long-Term Weight Loss From Lifestyle Intervention Benefits Blood Pressure?: A Systematic Review
Hypertension, October 1, 2009; 54(4): 756 - 762.
[Abstract] [Full Text] [PDF]


Home page
AMERICAN JOURNAL OF LIFESTYLE MEDICINEHome page
A. S. Leon and U. G. Bronas
Pathophysiology of Coronary Heart Disease and Biological Mechanisms for the Cardioprotective Effects of Regular Aerobic Exercise
American Journal of Lifestyle Medicine, September 1, 2009; 3(5): 379 - 385.
[Abstract] [PDF]


Home page
Br. J. Sports. Med.Home page
A Lucia, A De La Rosa, M A. Silvan, L M Lopez-Mojares, A Boraita, M Perez, C Foster, J Garcia-Castro, and M Ramirez
Mobilisation of mesenchymal cells in cardiac patients: is intense exercise necessary?
Br. J. Sports Med., March 1, 2009; 43(3): 221 - 223.
[Abstract] [Full Text] [PDF]


Home page
Health Educ ResHome page
M. E. Charlson, J. C. Peterson, C. Boutin-Foster, W. M. Briggs, G. G. Ogedegbe, C. E. McCulloch, J. Hollenberg, C. Wong, and J. P. Allegrante
Changing health behaviors to improve health outcomes after angioplasty: a randomized trial of net present value versus future value risk communication
Health Educ. Res., October 1, 2008; 23(5): 826 - 839.
[Abstract] [Full Text] [PDF]


Home page
Circ Heart FailHome page
R. Belardinelli, F. Lacalaprice, C. Ventrella, L. Volpe, and E. Faccenda
Waltz Dancing in Patients With Chronic Heart Failure: New Form of Exercise Training
Circ Heart Fail, July 1, 2008; 1(2): 107 - 114.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. M. Baca and G. R. Warnick
Estimation of LDL-Associated Apolipoprotein B from Measurements of Triglycerides and Total Apolipoprotein B
Clin. Chem., May 1, 2008; 54(5): 907 - 910.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. J. Taylor, J. Bindeman, I. Feuerstein, T. Le, K. Bauer, C. Byrd, H. Wu, and P. G. O'Malley
Community-Based Provision of Statin and Aspirin After the Detection of Coronary Artery Calcium Within a Community-Based Screening Cohort
J. Am. Coll. Cardiol., April 8, 2008; 51(14): 1337 - 1341.
[Abstract] [Full Text] [PDF]


Home page
Clin RehabilHome page
O. Lennon, A. Carey, N. Gaffney, J. Stephenson, and C. Blake
A pilot randomized controlled trial to evaluate the benefit of the cardiac rehabilitation paradigm for the non-acute ischaemic stroke population
Clinical Rehabilitation, February 1, 2008; 22(2): 125 - 133.
[Abstract] [PDF]


Home page
CirculationHome page
H. R. Superko and S. King III
Lipid Management to Reduce Cardiovascular Risk: A New Strategy Is Required
Circulation, January 29, 2008; 117(4): 560 - 568.
[Full Text] [PDF]


Home page
CMAJHome page
A. Wister PhD, N. Loewen MD, H. Kennedy-Symonds MHSc, B. McGowan MD, B. McCoy MA, and J. Singer PhD
One-year follow-up of a therapeutic lifestyle intervention targeting cardiovascular disease risk
Can. Med. Assoc. J., October 9, 2007; 177(8): 859 - 865.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
I. M. Singh, M. H. Shishehbor, and B. J. Ansell
High-Density Lipoprotein as a Therapeutic Target: A Systematic Review
JAMA, August 15, 2007; 298(7): 786 - 798.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
T. W. Rooke
Controversies in vascular screening art versus science
Vascular Medicine, August 1, 2007; 12(3): 235 - 242.
[Abstract] [PDF]


Home page
CirculationHome page
V. J. Dzau, E. M. Antman, H. R. Black, D. L. Hayes, J. E. Manson, J. Plutzky, J. J. Popma, and W. Stevenson
The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes: Part I: Pathophysiology and Clinical Trial Evidence (Risk Factors Through Stable Coronary Artery Disease)
Circulation, December 19, 2006; 114(25): 2850 - 2870.
[Full Text] [PDF]


Home page
CirculationHome page
L. H. Kuller
Prevention of Coronary Heart Disease and the National Cholesterol Education Program
Circulation, February 7, 2006; 113(5): 598 - 600.
[Full Text] [PDF]


Home page
CirculationHome page
M. E. Clouse, J. Chen, H. M. Krumholz, M. E. Clouse, J. Chen, and H. M. Krumholz
Noninvasive Screening for Coronary Artery Disease With Computed Tomography Is Useful
Circulation, January 3, 2006; 113(1): 125 - 146.
[Full Text] [PDF]


Home page
CirculationHome page
B. Fletcher, K. Berra, P. Ades, L. T. Braun, L. E. Burke, J. L. Durstine, J. M. Fair, G. F. Fletcher, D. Goff, L. L. Hayman, et al.
Managing Abnormal Blood Lipids: A Collaborative Approach
Circulation, November 15, 2005; 112(20): 3184 - 3209.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
A. M. Clark, L. Hartling, B. Vandermeer, and F. A. McAlister
Meta-Analysis: Secondary Prevention Programs for Patients with Coronary Artery Disease
Ann Intern Med, November 1, 2005; 143(9): 659 - 672.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. Abrams
Chronic Stable Angina
N. Engl. J. Med., June 16, 2005; 352(24): 2524 - 2533.
[Full Text] [PDF]


Home page
Vasc MedHome page
R. K Oka, E. Umoh, A. Szuba, J. C Giacomini, and J. P Cooke
Suboptimal intensity of risk factor modification in PAD
Vascular Medicine, May 1, 2005; 10(2): 91 - 96.
[Abstract] [PDF]


Home page
CirculationHome page
A. S. Leon, B. A. Franklin, F. Costa, G. J. Balady, K. A. Berra, K. J. Stewart, P. D. Thompson, M. A. Williams, and M. S. Lauer
Cardiac Rehabilitation and Secondary Prevention of Coronary Heart Disease: An American Heart Association Scientific Statement From the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity), in Collaboration With the American Association of Cardiovascular and Pulmonary Rehabilitation
Circulation, January 25, 2005; 111(3): 369 - 376.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
C. K. Roberts and R. J. Barnard
Effects of exercise and diet on chronic disease
J Appl Physiol, January 1, 2005; 98(1): 3 - 30.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
K. D. Flemming and R. D. Brown Jr
Secondary Prevention Strategies in Ischemic Stroke: Identification and Optimal Management of Modifiable Risk Factors
Mayo Clin. Proc., October 1, 2004; 79(10): 1330 - 1340.
[Abstract] [PDF]


Home page
The Annals of PharmacotherapyHome page
S.-F. Wong, J. G Jakowatz, and R. Taheri
Management of Hypertriglyceridemia in Patients Receiving Interferon for Malignant Melanoma
Ann. Pharmacother., October 1, 2004; 38(10): 1655 - 1659.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
R. M. Krauss
Lipids and Lipoproteins in Patients With Type 2 Diabetes
Diabetes Care, June 1, 2004; 27(6): 1496 - 1504.
[Abstract] [Full Text] [PDF]


Home page
Health Educ BehavHome page
A. Bandura
Health Promotion by Social Cognitive Means
Health Educ Behav, April 1, 2004; 31(2): 143 - 164.
[Abstract] [PDF]


Home page
CirculationHome page
R. Hambrecht, C. Walther, S. Mobius-Winkler, S. Gielen, A. Linke, K. Conradi, S. Erbs, R. Kluge, K. Kendziorra, O. Sabri, et al.
Percutaneous Coronary Angioplasty Compared With Exercise Training in Patients With Stable Coronary Artery Disease: A Randomized Trial
Circulation, March 23, 2004; 109(11): 1371 - 1378.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S. A. Lear, A. Ignaszewski, W. Linden, A. Brozic, M. Kiess, J. J. Spinelli, P. Haydn Pritchard, and J. J. Frohlich
The Extensive Lifestyle Management Intervention (ELMI) following cardiac rehabilitation trial
Eur. Heart J., November 1, 2003; 24(21): 1920 - 1927.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
D. J. Toobert, R. E. Glasgow, L. A. Strycker, M. Barrera Jr., J. L. Radcliffe, R. C. Wander, and J. D. Bagdade
Biologic and Quality-of-Life Outcomes From the Mediterranean Lifestyle Program: A randomized clinical trial
Diabetes Care, August 1, 2003; 26(8): 2288 - 2293.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Niebauer, A. J. Maxwell, P. S. Lin, D. Wang, P. S. Tsao, and J. P. Cooke
NOS inhibition accelerates atherogenesis: reversal by exercise
Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H535 - H540.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
A Jain, V Wadehra, and A D Timmis
Management of stable angina
Postgrad. Med. J., June 1, 2003; 79(932): 332 - 336.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
P. G. O'Malley, I. M. Feuerstein, and A. J. Taylor
Impact of Electron Beam Tomography, With or Without Case Management, on Motivation, Behavioral Change, and Cardiovascular Risk Profile: A Randomized Controlled Trial
JAMA, May 7, 2003; 289(17): 2215 - 2223.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. K. Williams, J. R. Kaplan, I. H. Suparto, J. L. Fox, and S. B. Manuck
Effects of Exercise on Cardiovascular Outcomes in Monkeys With Risk Factors for Coronary Heart Disease
Arterioscler Thromb Vasc Biol, May 1, 2003; 23(5): 864 - 871.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. T. Williams, H. R. Superko, W. L. Haskell, E. L. Alderman, P. J. Blanche, L. G. Holl, and R. M. Krauss
Smallest LDL Particles Are Most Strongly Related to Coronary Disease Progression in Men
Arterioscler Thromb Vasc Biol, February 14, 2003; 23(2): 314 - 321.
[Abstract] [Full Text] [PDF]


Home page
Behav ModifHome page
K. D. Graves and P. M. Miller
Behavioral Medicine in the Prevention and Treatment of Cardiovascular Disease
Behav Modif, January 1, 2003; 27(1): 3 - 25.
[Abstract] [PDF]


Home page
Behav ModifHome page
B. C. Bock, R. E. Carmona-Barros, J. L. Esler, and P. L. Tilkemeier
Program Participation and Physical Activity Maintenance after Cardiac Rehabilitation
Behav Modif, January 1, 2003; 27(1): 37 - 53.
[Abstract] [PDF]


Home page
CirculationHome page
References
Circulation, December 17, 2002; 106(25): 3373 - 3421.
[Full Text]


Home page
Eur Heart JHome page
P. Di Napoli, A.A. Taccardi, M. Oliver, and R. De Caterina
Statins and stroke: evidence for cholesterol-independent effects
Eur. Heart J., December 2, 2002; 23(24): 1908 - 1921.
[PDF]


Home page
Health Educ ResHome page
D. J. Toobert, L. A. Strycker, R. E. Glasgow, M. Barrera, and J. D. Bagdade
Enhancing support for health behavior change among women at risk for heart disease: the Mediterranean Lifestyle Trial
Health Educ. Res., October 1, 2002; 17(5): 574 - 585.
[Abstract] [Full Text] [PDF]


Home page
Health Educ ResHome page
M. E. Charlson, J. P. Allegrante, P. S. McKinley, J. C. Peterson, C. Boutin-Foster, G. Ogedegbe, and C. R. Young
Improving health behaviors and outcomes after angioplasty: using economic theory to inform intervention
Health Educ. Res., October 1, 2002; 17(5): 606 - 618.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. A. Ades, T. E. Kottke, N. Houston Miller, J. C. McGrath, N. B. Record, and S. S. Record
Task Force #3--getting results: who, where, and how?
J. Am. Coll. Cardiol., August 21, 2002; 40(4): 615 - 630.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Matsuzaki, K. Hiramori, T. Imaizumi, A. Kitabatake, H. Hishida, M. Nomura, T. Fujii, I. Sakuma, K. Fukami, T. Honda, et al.
Intravascular ultrasound evaluation of coronary plaque regression by low density lipoprotein-apheresis in familial hypercholesterolemia: The Low Density Lipoprotein-Apheresis Coronary Morphology and Reserve Trial (LACMART)
J. Am. Coll. Cardiol., July 17, 2002; 40(2): 220 - 227.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
B. Franklin, K. Bonzheim, J. Warren, S. Haapaniemi, N. Byl, and N. Gordon
Effects of a Contemporary, Exercise-Based Rehabilitation and Cardiovascular Risk-Reduction Program on Coronary Patients With Abnormal Baseline Risk Factors*
Chest, July 1, 2002; 122(1): 338 - 343.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
C. R. Lacy, D.-C. Suh, J. A. Barone, M. Bueno, D. Moylan, C. Swartz, R. V. Kudipudi, and J. B. Kostis
Impact of a Targeted Intervention on Lipid-Lowering Therapy in Patients With Coronary Artery Disease in the Hospital Setting
Arch Intern Med, February 25, 2002; 162(4): 468 - 473.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
E. J Schaefer
Lipoproteins, nutrition, and heart disease
Am. J. Clinical Nutrition, February 1, 2002; 75(2): 191 - 212.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
F. A McAlister, F. M E Lawson, K. K Teo, and P. W Armstrong
Randomised trials of secondary prevention programmes in coronary heart disease: systematic review
BMJ, October 27, 2001; 323(7319): 957 - 962.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Denollet and D. L. Brutsaert
Reducing Emotional Distress Improves Prognosis in Coronary Heart Disease: 9-Year Mortality in a Clinical Trial of Rehabilitation
Circulation, October 23, 2001; 104(17): 2018 - 2023.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
S. D. Fihn, S. V. Williams, J. Daley, and R. J. Gibbons
Guidelines for the Management of Patients with Chronic Stable Angina: Treatment
Ann Intern Med, October 16, 2001; 135(8_Part_1): 616 - 632.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. F. Fletcher, G. J. Balady, E. A. Amsterdam, B. Chaitman, R. Eckel, J. Fleg, V. F. Froelicher, A. S. Leon, I. L. Pina, R. Rodney, et al.
Exercise Standards for Testing and Training: A Statement for Healthcare Professionals From the American Heart Association
Circulation, October 2, 2001; 104(14): 1694 - 1740.
[Full Text] [PDF]


Home page
NEJMHome page
P. A. Ades
Cardiac Rehabilitation and Secondary Prevention of Coronary Heart Disease
N. Engl. J. Med., September 20, 2001; 345(12): 892 - 902.
[Full Text] [PDF]


Home page
Eur Heart JHome page
A Baessler, C Hengstenberg, S Holmer, M Fischer, B Mayer, U Hubauer, G Klein, G Riegger, and H Schunkert
Long-term effects of in-hospital cardiac rehabilitation on the cardiac risk profile. A case-control study in pairs of siblings with myocardial infarction
Eur. Heart J., July 1, 2001; 22(13): 1111 - 1118.
[Abstract] [PDF]


Home page
Eur Heart J SupplHome page
T.D. Barringer
Dietary fats in the prevention of coronary heart disease: the need for more clinical trials
Eur. Heart J. Suppl., June 1, 2001; 3(suppl_D): D79 - D84.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
H. S. Hecht and H. R. Superko
Electron beam tomography and national cholesterol education program guidelines in asymptomatic women
J. Am. Coll. Cardiol., May 1, 2001; 37(6): 1506 - 1511.
[Abstract] [Full Text] [PDF]


Home page
J Gerontol A Biol Sci Med SciHome page
I-M. Lee, S. N. Blair, D. B. Allison, A. R. Folsom, T. B. Harris, J. E. Manson, and R. R. Wing
Epidemiologic Data on the Relationships of Caloric Intake, Energy Balance, and Weight Gain Over the Life Span With Longevity and Morbidity
J Gerontol A Biol Sci Med Sci, March 1, 2001; 56(suppl_1): 7 - 19.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S.N Willich, J Muller-Nordhorn, M Kulig, S Binting, H Gohlke, H Hahmann, K Bestehorn, K Krobot, and H Voller
Cardiac risk factors, medication, and recurrent clinical events after acute coronary disease. A prospective cohort study
Eur. Heart J., February 2, 2001; 22(4): 307 - 313.
[Abstract] [PDF]


Home page
Am. J. Clin. Nutr.Home page
E. J Parks
A targeted goal for energy-restricted diets in the management of coronary risk?
Am. J. Clinical Nutrition, February 1, 2001; 73(2): 147 - 148.
[Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
F. B. Hu, J. E. Manson, and W. C. Willett
Types of Dietary Fat and Risk of Coronary Heart Disease: A Critical Review
J. Am. Coll. Nutr., February 1, 2001; 20(1): 5 - 19.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
T. A. Lakka, J. A. Laukkanen, R. Rauramaa, R. Salonen, H.-M. Lakka, G. A. Kaplan, and J. T. Salonen
Cardiorespiratory Fitness and the Progression of Carotid Atherosclerosis in Middle-Aged Men
Ann Intern Med, January 2, 2001; 134(1): 12 - 20.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Gielen, G. Schuler, and R. Hambrecht
Exercise Training in Coronary Artery Disease and Coronary Vasomotion
Circulation, January 2, 2001; 103 (1): e1 - e6.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
J. G. Fodor, J. J. Frohlich, J. J.G. Genest Jr., P. R. McPherson, and for the Working Group on Hypercholesterolemia and
Recommendations for the management and treatment of dyslipidemia: Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias
Can. Med. Assoc. J., May 16, 2000; 162(10): 1441 - 1447.
[Full Text] [PDF]


Home page
NEJMHome page
R. Hambrecht, A. Wolf, S. Gielen, A. Linke, J. Hofer, S. Erbs, N. Schoene, and G. Schuler
Effect of Exercise on Coronary Endothelial Function in Patients with Coronary Artery Disease
N. Engl. J. Med., February 17, 2000; 342(7): 454 - 460.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
T.F.M. Van Berkel, H. Boersma, J.W. Roos-Hesselink, R.A.M. Erdman, and M.L. Simoons
Impact of smoking cessation and smoking interventions in patients with coronary heart disease
Eur. Heart J., December 2, 1999; 20(24): 1773 - 1782.
[PDF]


Home page
J. Appl. Physiol.Home page
T. M. Rywik, M. R. Blackman, A. R. Yataco, P. V. Vaitkevicius, R. C. Zink, E. H. Cottrell, J. G. Wright, L. I. Katzel, and J. L. Fleg
Enhanced endothelial vasoreactivity in endurance-trained older men
J Appl Physiol, December 1, 1999; 87(6): 2136 - 2142.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C. Hofman-Bang, J. Lisspers, R. Nordlander, A. Nygren, O. Sundin, A. Ohman, and L. Ryden
Two-year results of a controlled study of residential rehabilitation for patients treated with percutaneous transluminal coronary angioplasty. A randomized study of a multifactorial programme
Eur. Heart J., October 2, 1999; 20(20): 1465 - 1474.
[Abstract] [PDF]


Home page
Eur Heart JHome page
A. Kleemann, S. Eckert, A. von Eckardstein, W. Lepper, U. Schernikau, U. Gleichmann, P. Hanrath, E. Fleck, A. Neiss, S. Kerber, et al.
Effects of lovastatin on progression of non-dilated and dilated coronary segments and on restenosis in patients after PTCA. The Cholesterol Lowering Atherosclerosis PTCA Trial (CLAPT)
Eur. Heart J., October 1, 1999; 20(19): 1393 - 1406.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. V. Huikuri, V. Jokinen, M. Syvanne, M. S. Nieminen, K. E. J. Airaksinen, M. J. Ikaheimo, J. M. Koistinen, H. Kauma, A. Y. Kesaniemi, S. Majahalme, et al.
Heart Rate Variability and Progression of Coronary Atherosclerosis
Arterioscler Thromb Vasc Biol, August 1, 1999; 19(8): 1979 - 1985.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
P. N. Herbert, M. Miller, S. A. Lear, and D. Ornish
Effect of Lifestyle Changes on Coronary Heart Disease
JAMA, July 14, 1999; 282(2): 130 - 132.
[Full Text] [PDF]


Home page
CirculationHome page
L. Campeau, D. B. Hunninghake, G. L. Knatterud, C. W. White, M. Domanski, S. A. Forman, J. S. Forrester, N. L. Geller, F. L. Gobel, J. A. Herd, et al.
Aggressive Cholesterol Lowering Delays Saphenous Vein Graft Atherosclerosis in Women, the Elderly, and Patients With Associated Risk Factors : NHLBI Post Coronary Artery Bypass Graft Clinical Trial
Circulation, June 29, 1999; 99(25): 3241 - 3247.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. J. Gibbons, K. Chatterjee, J. Daley, J. S. Douglas, S. D. Fihn, J. M. Gardin, M. A. Grunwald, D. Levy, B. W. Lytle, R. A. O'Rourke, et al.
ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina)
J. Am. Coll. Cardiol., June 1, 1999; 33(7): 2092 - 2197.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
C. von Schacky, P. Angerer, W. Kothny, K. Theisen, and H. Mudra
The Effect of Dietary {omega}-3 Fatty Acids on Coronary Atherosclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial
Ann Intern Med, April 6, 1999; 130(7): 554 - 562.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. J. Shephard and G. J. Balady
Exercise as Cardiovascular Therapy
Circulation, February 23, 1999; 99(7): 963 - 972.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. C. Bucher, L. E. Griffith, and G. H. Guyatt
Systematic Review on the Risk and Benefit of Different Cholesterol-Lowering Interventions
Arterioscler Thromb Vasc Biol, February 1, 1999; 19(2): 187 - 195.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Rabbani and E. J. Topol
Strategies to achieve coronary arterial plaque stabilization
Cardiovasc Res, February 1, 1999; 41(2): 402 - 417.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
D. Ornish, L. W. Scherwitz, J. H. Billings, K. L. Gould, T. A. Merritt, S. Sparler, W. T. Armstrong, T. A. Ports, R. L. Kirkeeide, C. Hogeboom, et al.
Intensive Lifestyle Changes for Reversal of Coronary Heart Disease
JAMA, December 16, 1998; 280(23): 2001 - 2007.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
H. Buchwald, R. L. Varco, J. R. Boen, S. E. Williams, B. J. Hansen, C. T. Campos, G. S. Campbell, M. B. Pearce, A. E. Yellin, W. A. Edmiston, et al.
Effective Lipid Modification by Partial Ileal Bypass Reduced Long-term Coronary Heart Disease Mortality and Morbidity: Five-Year Posttrial Follow-up Report From the POSCH
Arch Intern Med, June 8, 1998; 158(11): 1253 - 1261.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
P. S. Gartside, P. Wang, and C. J. Glueck
Prospective Assessment of Coronary Heart Disease Risk Factors: The NHANES I Epidemiologic Follow-up Study (NHEFS) 16-Year Follow-up
J. Am. Coll. Nutr., June 1, 1998; 17(3): 263 - 269.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Niebauer, R. Hambrecht, T. Velich, K. Hauer, C. Marburger, B. Kalberer, C. Weiss, E. von Hodenberg, G. Schlierf, G. Schuler, et al.
Attenuated Progression of Coronary Artery Disease After 6 Years of Multifactorial Risk Intervention : Role of Physical Exercise
Circulation, October 21, 1997; 96(8): 2534 - 2541.
[Abstract] [Full Text]


Home page
CirculationHome page
M. H. Frick, M. Syvanne, M. S. Nieminen, H. Kauma, S. Majahalme, V. Virtanen, Y. A. Kesaniemi, A. Pasternack, and M.-R. Taskinen
Prevention of the Angiographic Progression of Coronary and Vein-Graft Atherosclerosis by Gemfibrozil After Coronary Bypass Surgery in Men With Low Levels of HDL Cholesterol
Circulation, October 7, 1997; 96(7): 2137 - 2143.
[Abstract] [Full Text]


Home page
JAMAHome page
H. G. Schrott, V. Bittner, E. Vittinghoff, D. M. Herrington, and S. Hulley
Adherence to National Cholesterol Education Program Treatment Goals in Postmenopausal Women With Heart Disease: The Heart and Estrogen/Progestin Replacement Study (HERS)
JAMA, April 23, 1997; 277(16): 1281 - 1286.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. T. Williams, D. M. Dreon, P. J. Blanche, and R. M. Krauss
Variability of Plasma HDL Subclass Concentrations in Men and Women Over Time
Arterioscler Thromb Vasc Biol, April 1, 1997; 17(4): 702 - 706.
[Abstract] [Full Text]


Home page
NEJMHome page
The Post Coronary Artery Bypass Graft Trial Invest
The Effect of Aggressive Lowering of Low-Density Lipoprotein Cholesterol Levels and Low-Dose Anticoagulation on Obstructive Changes in Saphenous-Vein Coronary-Artery Bypass Grafts
N. Engl. J. Med., January 16, 1997; 336(3): 153 - 163.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. D. Miller, E. L. Alderman, W. L. Haskell, J. M. Fair, and R. M. Krauss
Predominance of Dense Low-Density Lipoprotein Particles Predicts Angiographic Benefit of Therapy in the Stanford Coronary Risk Intervention Project
Circulation, November 1, 1996; 94(9): 2146 - 2153.
[Abstract] [Full Text]


Home page
CirculationHome page
P. S. Tsao, R. Buitrago, J. R. Chan, and J. P. Cooke
Fluid Flow Inhibits Endothelial Adhesiveness: Nitric Oxide and Transcriptional Regulation of VCAM-1
Circulation, October 1, 1996; 94(7): 1682 - 1689.
[Abstract] [Full Text]


Home page
CirculationHome page
D. Waters, J. Lesperance, P. Gladstone, S. J. Boccuzzi, T. Cook, R. Hudgin, G. Krip, and L. Higginson
Effects of Cigarette Smoking on the Angiographic Evolution of Coronary Atherosclerosis: A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Substudy
Circulation, August 15, 1996; 94(4): 614 - 621.
[Abstract] [Full Text]


Home page
CirculationHome page
G. F. Fletcher, G. Balady, S. N. Blair, J. Blumenthal, C. Caspersen, B. Chaitman, S. Epstein, E. S. S. Froelicher, V. F. Froelicher, I. L. Pina, et al.
Statement on Exercise: Benefits and Recommendations for Physical Activity Programs for All Americans: A Statement for Health Professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart Association
Circulation, August 15, 1996; 94(4): 857 - 862.
[Full Text]


Home page
NEJMHome page
M. Enriquez-Sarano, E. Klodas, K. N. Garratt, K. R. Bailey, A. J. Tajik, and D. R. Holmes
Secular Trends in Coronary Atherosclerosis -- Analysis in Patients with Valvular Regurgitation
N. Engl. J. Med., August 1, 1996; 335(5): 316 - 322.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. R. Pedersen, J. Kjekshus, K. Berg, A. G. Olsson, L. Wilhelmsen, H. Wedel, K. Pyorala, T. Miettinen, T. Haghfelt, O. Færgeman, et al.
Cholesterol Lowering and the Use of Healthcare Resources : Results of the Scandinavian Simvastatin Survival Study
Circulation, May 15, 1996; 93(10): 1796 - 1802.
[Abstract] [Full Text]


Home page
CirculationHome page
A. A. Kroon, W. R.M. Aengevaeren, T. van der Werf, G. J.H. Uijen, J. H.C. Reiber, A. V.G. Bruschke, and A. F.H. Stalenhoef
LDL-Apheresis Atherosclerosis Regression Study (LAARS) : Effect of Aggressive Versus Conventional Lipid Lowering Treatment on Coronary Atherosclerosis
Circulation, May 15, 1996; 93(10): 1826 - 1835.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Suurkula, S. Agewall, B. Fagerberg, I. Wendelhag, and J. Wikstrand
Multiple Risk Intervention in High-Risk Hypertensive Patients : A 3-Year Ultrasound Study of Intima-Media Thickness and Plaques in the Carotid Artery
Arterioscler Thromb Vasc Biol, March 1, 1996; 16(3): 462 - 470.
[Abstract] [Full Text]


Home page
CirculationHome page
M. N. Hill and N. Houston Miller
Compliance Enhancement : A Call for Multidisciplinary Team Approaches
Circulation, January 1, 1996; 93(1): 4 - 6.
[Full Text]


Home page
CirculationHome page
L. Lacoste, J. Y.T. Lam, J. Hung, G. Letchacovski, C. B. Solymoss, and D. Waters
Hyperlipidemia and Coronary Disease : Correction of the Increased Thrombogenic Potential With Cholesterol Reduction
Circulation, December 1, 1995; 92(11): 3172 - 3177.
[Abstract] [Full Text]


Home page
CirculationHome page
D. Waters, L. Higginson, P. Gladstone, S. J. Boccuzzi, T. Cook, and J. Lesperance
Effects of Cholesterol Lowering on the Progression of Coronary Atherosclerosis in Women : A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Substudy
Circulation, November 1, 1995; 92(9): 2404 - 2410.
[Abstract] [Full Text]


Home page
JAMAHome page
K. L. Gould, D. Ornish, L. Scherwitz, S. Brown, R. P. Edens, M. J. Hess, N. Mullani, L. Bolomey, F. Dobbs, W. T. Armstrong, et al.
Changes in Myocardial Perfusion Abnormalities by Positron Emission Tomography After Long-term, Intense Risk Factor Modification
JAMA, September 20, 1995; 274(11): 894 - 901.
[Abstract] [PDF]


Home page
JAMAHome page
J. J. Mason, D. K. Owens, R. A. Harris, J. P. Cooke, and M. A. Hlatky
The Role of Coronary Angiography and Coronary Revascularization Before Noncardiac Vascular Surgery
JAMA, June 28, 1995; 273(24): 1919 - 1925.
[Abstract] [PDF]


Home page
CirculationHome page
J. W. Jukema, A. V.G. Bruschke, A. J. van Boven, J. H.C. Reiber, E. T. Bal, A. H. Zwinderman, H. Jansen, G. J.M. Boerma, F. M. van Rappard, and K. I. Lie
Effects of Lipid Lowering by Pravastatin on Progression and Regression of Coronary Artery Disease in Symptomatic Men With Normal to Moderately Elevated Serum Cholesterol Levels : The Regression Growth Evaluation Statin Study (REGRESS)
Circulation, May 15, 1995; 91(10): 2528 - 2540.
[Abstract] [Full Text]


Home page
JAMAHome page
D. Stokols, K. R. Pelletier, and J. E. Fielding
Integration of Medical Care and Worksite Health Promotion
JAMA, April 12, 1995; 273(14): 1136 - 1142.
[Abstract] [PDF]


Home page
BMJHome page
A S Wierzbicki and T M Reynolds
Health promotion in general practice
BMJ, February 25, 1995; 310(6978): 532c - 533.
[Full Text]


Home page
NEJMHome page
G. N. Levine, J. F. Keaney, and J. A. Vita
Cholesterol Reduction in Cardiovascular Disease -- Clinical Benefits and Possible Mechanisms
N. Engl. J. Med., February 23, 1995; 332(8): 512 - 521.
[Full Text] [PDF]